Eating Peanuts for Health

June 21, 2013 updated by: Richard Mattes, Purdue University

Peanut Consumption and Human Weight Management

Evidence is accumulating that peanut consumption confers health benefits, such as reduction of cardiovascular disease risk and possibly diabetes risk (Jenkins et al., 2008; Mattes et al., 2008). However, peanuts are a high fat, energy dense food and concerns about weight gain are widespread. Although research indicates that other characteristics of peanuts offset these properties, and that peanuts may be incorporated into diets without posing a threat to weight gain (Mattes et al., 2008), concern remains among policymakers, healthcare providers, and consumers. Furthermore, worry exists that eating salted peanuts may elevate blood pressure and that eating honey-roasted peanuts make elevate blood sugar. These fears create substantial obstacles to increased peanut consumption.

Recommendations to increase peanut consumption may be made, but if they are not followed, there will be no impact on health. Additional knowledge is needed on: (1) the acceptability of peanuts consumed on a chronic basis, (2) the chronic intake of moderate levels of peanuts and body weight, and 3) the effects of peanuts on blood pressure and blood sugar. The proposed research will examine the acceptability of long-term inclusion of a single form versus varied forms of peanuts in the diet. It is expected that responses will be varied among individuals with different personality characteristics (e.g., prefer sweet versus savory foods, hedonic versus non-hedonic eaters). A better understanding of how different segments of the population choose to include peanuts in their diet and how to optimize long-term consumption should provide insights for better marketing and improved health. Furthermore, it is anticipated that eating salty peanuts will not raise blood pressure and that eating honey-roasted peanuts will not raise blood sugar. Documenting this will add credibility to the evidence that peanuts do not cause weight gain, as well as reinforce recommendations to increase peanut consumption for their health benefits.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

196

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • West Lafayette, Indiana, United States, 47907
        • Purdue University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Between 18 and 50 years of age
  • Weight stable (< 3 kg weight change within last 3 months)
  • Constant habitual activity patterns (no deviation > 1x/wk at 30 min/session within last 3 months)
  • Constant habitual diet patterns within last 3 months
  • Willingness to eat all test foods (peanuts daily for 12 weeks)
  • No allergy to foods provided in the study (peanuts)
  • Not a daily peanut or tree nut consumer
  • Not planning to change use of medications known to influence appetite or metabolism
  • Not diabetic or hypertensive
  • No history of gastrointestinal pathology
  • Non-smoker for one year or more

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Consumption of 42 g of salted peanuts
Consumption of 42 grams of peanuts daily
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)
Experimental: Consumption of 42 g of unsalted peanuts
Consumption of 42 grams of peanuts daily
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)
Experimental: Consumption of 42 g of spicy peanuts
Consumption of 42 grams of peanuts daily
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)
Experimental: Consumption of 42 g of honey peanuts
Consumption of 42 grams of peanuts daily
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)
Experimental: Consumption of 42 g of 3 diff. varieties
Consumption of 42 grams of peanuts daily
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)
Experimental: Consumption of 42 g of var. of types
Consumption of 42 grams of peanuts daily
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Weight
Time Frame: 2, 4, 6, 8, 10, and 12 weeks
2, 4, 6, 8, 10, and 12 weeks
Change in Blood Lipids
Time Frame: 4, 8, and 12 weeks
4, 8, and 12 weeks
Change in Blood Pressure
Time Frame: 2, 4, 6, 8, 10, and 12 weeks
2, 4, 6, 8, 10, and 12 weeks
Change in Hedonics of peanut consumption
Time Frame: 12 weeks
Participants will rate their liking of the sample each day using a visual analog scale.
12 weeks
Change in Body Composition
Time Frame: 2, 4, 6, 8, 10, and 12 weeks
2, 4, 6, 8, 10, and 12 weeks
Change in Fasting Blood Glucose
Time Frame: 4, 8, and 12 weeks
4, 8, and 12 weeks
Change in Cortisol
Time Frame: 4, 8, and 12 weeks
4, 8, and 12 weeks
Change in Insulin
Time Frame: 4, 8, and 12 weeks
4, 8, and 12 weeks
Change in Pulse
Time Frame: 2, 4, 6, 8, 10, and 12 weeks
2, 4, 6, 8, 10, and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personality Questionnaires
Time Frame: At baseline visit
At baseline visit
Flavor attribute liking measures
Time Frame: At baseline
At baseline
Compliance
Time Frame: 12 weeks
Participants will self-report compliance to study protocol using record sheets.
12 weeks
Appetitive Ratings
Time Frame: 4, 8, and 12 weeks
Collected on handheld computer
4, 8, and 12 weeks
Consumption Parameters
Time Frame: 12 weeks
Participants will note if peanuts were eaten as a meal or snack, at what time, and with what other foods daily.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Richard D Mattes, RD, MPH, PhD, Purdue University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2010

Primary Completion (Actual)

May 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

June 19, 2013

First Submitted That Met QC Criteria

June 21, 2013

First Posted (Estimate)

June 25, 2013

Study Record Updates

Last Update Posted (Estimate)

June 25, 2013

Last Update Submitted That Met QC Criteria

June 21, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Consumption of 42 grams of peanuts daily

Subscribe